Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Many Egyptian women who were hospitalized for COVID-19 experienced significant hair loss afterwards.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

People with alopecia areata have different blood markers that suggest inflammation and immune system issues compared to healthy individuals.

People with hair loss conditions often have more mental health issues like depression and anxiety compared to those without hair loss.

Most children with rapid hair loss had a known cause, with stress and illness being top triggers, and treatments showed similar improvement.

A woman with a long-term skin condition developed a serious skin cancer that led to her death.

Telogen effluvium is a common, reversible hair loss condition treatable with patient education and sometimes Minoxidil.

Telogen effluvium is a common, temporary hair loss condition often affecting young women.

Alopecia areata incognita causes sudden hair thinning, responds well to steroids, and is more common in those with genetic hair loss conditions.